Serafino Pantano
- Cancer Research top 2%
- NF-κB Signaling Pathways 3
- Immunology top 5%
- Immune Response and Inflammation 4
- interferon and immune responses 2
- Reproductive Medicine top 2%
- Oncology top 5%
- Lung Cancer Research Studies 2
- Nephrology top 5%
-
- Genetic Syndromes and Imprinting 5
-
- Lung Cancer Treatments and Mutations 3
-
- Prenatal Screening and Diagnostics 2
-
- Congenital heart defects research 2
- Co-authors
- Gioacchino NatoliSimona SaccaniAntonino ForaboscoMinoru S.H. KoDavide BizzaroPaola AzzoniPatrizia BianchiUmberto Bianchi
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Serafino Pantano
18 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 730
- Immunology 752
- Reproductive Medicine 263
- Oncology 684
- Nephrology 155
Countries citing papers authored by Serafino Pantano
This map shows the geographic impact of Serafino Pantano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serafino Pantano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serafino Pantano more than expected).
Fields of papers citing papers by Serafino Pantano
This network shows the impact of papers produced by Serafino Pantano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serafino Pantano. The network helps show where Serafino Pantano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Serafino Pantano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 7 | |
| 2 | Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trialbreakdown → | 2017 | 412 |
| 3 | 2016 | 13 | |
| 4 | 2014 | 21 | |
| 5 | 2013 | 3 | |
| 6 | 2010 | 36 | |
| 7 | 2010 | 263 | |
| 8 | 2006 | 11 | |
| 9 | 2003 | 247 | |
| 10 | 2001 | 323 | |
| 11 | 2001 | 54 | |
| 12 | p38-dependent marking of inflammatory genes for increased NF-κB recruitmentbreakdown → | 2001 | 600 |
| 13 | 2000 | 97 | |
| 14 | 2000 | 21 | |
| 15 | 2000 | 345 | |
| 16 | 1998 | 94 | |
| 17 | 1998 | 0 | |
| 18 | 1997 | 53 | |
| 19 | 1995 | 239 |
About Serafino Pantano
Serafino Pantano is a scholar working on Developmental Biology, Cancer Research and Oncology, having authored 19 papers that have together received 2.8k indexed citations. Recurring topics across this work include Genetic Syndromes and Imprinting (5 papers), Immune Response and Inflammation (4 papers), Lung Cancer Treatments and Mutations (3 papers), NF-κB Signaling Pathways (3 papers), interferon and immune responses (2 papers), Prenatal Screening and Diagnostics (2 papers), Congenital heart defects research (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Cancer Research (730 citations), Immunology (752 citations) and Reproductive Medicine (263 citations). Serafino Pantano has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Gioacchino Natoli, Simona Saccani, Antonino Forabosco, Minoru S.H. Ko, Davide Bizzaro, Paola Azzoni, Patrizia Bianchi, Umberto Bianchi, Gian Carlo Manicardi and Denny Sakkas. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.